Co-Formulation of Pembrolizumab Murine Surrogate RMP1-14 with Imagent ® Ultrasound Contrast Agent Enhances Intratumoral Antibody Delivery Through a Transient Increase in Tumor Blood Perfusion.
Saved in:
| Title: | Co-Formulation of Pembrolizumab Murine Surrogate RMP1-14 with Imagent ® Ultrasound Contrast Agent Enhances Intratumoral Antibody Delivery Through a Transient Increase in Tumor Blood Perfusion. |
|---|---|
| Authors: | Kirven, Imani A.1 (AUTHOR), Penfornis, Patrice1,2 (AUTHOR), Siddiqui, Muhammad R.2,3 (AUTHOR), Butler, Kenneth R.1,4 (AUTHOR), Roman, Richard J.1 (AUTHOR), Larsen, Clayton T.2,3 (AUTHOR), Howard, Candace M.3,4 (AUTHOR), Claudio, Pier Paolo1,4 (AUTHOR) pclaudio@umc.edu |
| Source: | Pharmaceutics. Jun2026, Vol. 18 Issue 6, p690. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19994923 |
|---|---|
| DOI: | 10.3390/pharmaceutics18060690 |
